Concepedia

Shohei Sakata

SS

4

Publications

137

Citations

4

H-Index

2009

Active since

Affiliations

Japan Tobacco (Japan)(Current)

Shohei Sakata is an author at Japan Tobacco (Japan) specializing in metabolic syndrome, diabetes, and medicine.

Top concepts

DiabetesMedicineBiochemistryPharmacologyMetabolic SyndromeHealthObesityNutritionMetabolismPhysiology

Publications per year

2009–2018

4

Publications

4

Pharmacological profiles of a novel protein tyrosine phosphatase 1B inhibitor, JTT‐551

Sumiaki Fukuda, Takeshi Ohta, Shohei Sakata et al. · Diabetes Obesity and Metabolism · 2009 · 64 citations

Pharmacological Effects of JTT-551, a Novel Protein Tyrosine Phosphatase 1B Inhibitor, in Diet-Induced Obesity Mice

Makoto Ito, Sumiaki Fukuda, Shohei Sakata et al. · Journal of Diabetes Research · 2014 · 31 citations · Full text

Nutrition, Metabolic Disorder, Insulin Signaling +21

Discovery of potent liver-selective stearoyl-CoA desaturase-1 (SCD1) inhibitors, thiazole-4-acetic acid derivatives, for the treatment of diabetes, hepatic steatosis, and obesity

Tetsuya Iida, Minoru Ubukata, Ikuo MITANI et al. · European Journal of Medicinal Chemistry · 2018 · 29 citations · Full text

Metabolic Syndrome, Medicinal Chemistry, Lipid Synthesis +13

JTP-103237, a monoacylglycerol acyltransferase inhibitor, prevents fatty liver and suppresses both triglyceride synthesis and de novo lipogenesis

Chihiro Okuma, Takeshi Ohta, Hironobu Tadaki et al. · Journal of Pharmacological Sciences · 2015 · 13 citations · Full text

Rows per page

1–4 of 4